CRTC2 and autosomal dominant polycystic kidney disease: Recent studies indicate that several small molecules that specifically target the formation of phase‐separated condensates hold promise in disease intervention.[67, 68] Searching for inhibitors targeting the CRTC2 condensates may therefore be useful for developing new therapeutics for ADPKD.